11-oxygenated derivatives of 13-methyl-17-hydroxy-17(beta-hydroxyacetyl)-1, 2, 3, 6,7, 8, 9, 10, 11, 12, 13, 14, 16, 17-tetradecahydro-15h-cyclopenta [a] phenanthren-3-ones and esters thereof



United States PatentO IhOXYGENATE DE V I E i 9 -.ME HY l. :HYDRDX d -(BrHYDROXYA E ,3, 3, 0,11, 2 1 6, r IRADE A Y R K- YCLQI N AMF NT T 3 'DNE AN "ESTERS THEREOF Frank B. Colton, Chicago, Ill., assignor,

ments, to G. D.,Sear'le & Co., tion of Delaware No Drawing. Application October 9, 1953, ,Serial No. 385,288

6 Claims. (Cl. 260---397.45)

by mesne assign- Skokie, Ill., a corpora- The present invention relates to a new group of organic polycyclic compounds and more specifically, to the ll-hydroxyand ll-oxoderivatives of 13-methyl-17- hydroxy, 1, 2, 3, 6, 7,8,9,10,11,12,l3,14,16,17 tetradecahydro-15H-cyclopenta[alphenanthren-B ones substituted 1 5 in-,the ll-positign, by a member. ofthe class. consisting of .Ihs ssmwsnq his w s tufi th in sat s sa be .xs sssm d .1 1111 snsra EWRFPW, tqmwl whereinX is a carbinol or carbonyLandR is a hydrogen, benzoyl, or a (lower allgyD-CO- radical. i

'lhe compounds which constitute this invention can be prepared-by -methods described iniapplican ts following copending applications of which. the present application is a continuation-impart: Serial Number 28 6, 6 l1,; filed May 7, 1952, issued as U. S. Patent 2,655,518 on Octog-ber 1'3, 19 53; Serial Number 357,3 7-7,'filed May 25, 1-953,; issued-as U. 8. Patent 2,704,768 on March 22, 1 955; and: Serial Number 357,375, filed -May 25, 1953, 1 jointly-by applicant and Dr. I. WLRalls, issued as U. S. uPaterit 2,694,080 on-November 9,1954.

The compounds of myi'nverition are of .great value .because of their .unusilal adrenocorticoid "activity. Ilike their 1 O-methyl derivatives, they possessa 'n eoglycogenet- Mic effect. However, they differ from these l0-irie thyl derivatives .in lacking some of theside reactions which --limit their clinical applicability, in possessing apotent eiiect .on stress resistance and in the ability tomaintain life -in adrenocortical deficiency states.'

The examples below illustrate .thecompoundsof my invention andithe methods for their production. However, the inyention is not to be construed as limited by the details set forth in spirit or in scope. It will be apparent to those sk-illed ,in the art that many modifications in materials and methods'hc anbe practiced without departing. from the invention. In each of these examples temperatures are given indegrees centigrade C.) and relative amounts of materials in parts by weight.

Example 1 A stirred solution of 10.6 parts of 3-methoXy-13- methyl-1,4,6,7,8,9,11,12,13,14,16,17-dodecahydro 15H- cyclopentalalphenanthren-ll one in 7 00 p arts of anhyrdrousether and 45 .pajrts of drytolueneiis cooled to 0? C. .and vsaturat dw th dry cety ene Whi e 0 .9w; l i i i 2,802,015 Patented Aug. 6, 1957 2 acetylene ispassedthrough the reaction mixture, a solution of parts 0t potassium t-amylate in 135 partsof anhydrous tertiary amyl alcohol is added inthe course of 15 minutes with stirring. Passage of acetylene-and 5 stirring are-continued for an additional 4 /2 hours. After standing at 0 C for 16hours, the mixture is. washed with aqueous ammonium chloride solution until the 'aqueous phase is neutral, then with water and saturated sodium chloridesolution. Theorganic layer is dried over anhy- 10 adrous sodium sulfate, filtered and concentrated under vacuum toaresidue -of about 250 parts. 500-parts of petroleum T ether are added and, after-standing at 0 C. v for an hour, the mixture is filtered. The collected precipitate is recrystallized mfromsether. "The resulting '3- 15.rnethoxyal3rmethyl-l7 -.eth-yny1 1,4,6,7,8,9,11,12,13,l4,

-16,17-do.decahydro#1'5H-cyclopenta[aJPhenanthren 17- .tolamelts.atuaboutal8l-l82".C. The rotation as deter- .,mined..in.a 1:% chloroform solution is [al =-I-65. An nadditionalsamount of thisproduet can beobtained from 20 the. mothenliquorstby concentration under vacuum followed: by addition of petroleum ether.

#Toa refluxingasolution. of 47.5 parts of 3-rnethoxy-l3- methyl-17-ethynyl-1,4,6,7,8,9,11,12,l3,14,]16,l7 :dodecahydro-ISH-cyclopenta[alphenanthren-17-ol in 3200 parts of methanol andrl000 parts of water are added 240 parts of concentrated hydrochloric acid. Refiuxing is continued for an additional 5 minutes after which the solution is maintained at room temperature for 15 minutes. Then 13,000 parts of;water are added and the mixture is cooled to 0 C. After standing for several hours at that temperature, the mixtureis filtered and the precipitate is dried and crystallized from ethyl acetate. The l3-methyl- 17-ethynyl-17-hydroxy 1,2,3,6,7,8,9,10,11,12,13,l4,16,17- tetradecahydro-ISH-cyclopenta [a] phenanthren-3-one thus obtained melts at about 202 20 4" C. The specific rotation', asljdeterm inedl'in a 1% chloroform .solution is [otl --2 2.51". Thel ultraviolet absorptionspectrum of amethanolicsolution shows. a maximum at 241 millimicroiis with lahmoleculari extinction coefiicient of 17,100.

40" i A solution'o'f 53.7 partsof 13-methyl-17-ethynyl-17- hydroxy-1,2',3,6,7,8,9,10,11,12,l3,14,l6,17 tetradecahyfdro-15H-cyclopenta[aJphenanthren-3 one in 1500 parts of dioxane and 1000 parts of pyridine is reduced in an atmosphere of hydrogen over 30 parts of a catalyst containing '5%' palladium on calcium carbonate. On ab sprption offo nemolecule of hydrogen the reduction is stopped and themixtuie is-filtered. "The filtrate'is concentrated under vacuum toabout 500 parts, diluted with 3000 parts of ether and ashed with normal hydrochloric acid until. aCongo .red test shows an acidic reaction. The solution is washed successively with water, 5% sodium bicarbonate, water and saturated sodium chloride solution. The ether extract is driedjov'er sodium sulfate, concentrated on the steam bath to about 500 parts and diluted with 800 parts of petroleum ether. After storage at 0 C. for 16 hours, the product is collectedon a filter, dried and crystallized from a mixture of ethyl acetate and petroleurn ether. The 13-methyl-l7-viuyl-l7-hydroXy-1,2,3,6, 7,8,9,10,11,12,13,14,16,17-tetradecahydro 15H cyclopenta[alphenanthren-3-one thus obtained melts at about 169-171" C. The rotation "of an alcoholic solution is v "o'lution of 47.3 parts of phosphorus tribromide i 6 :fp'la'rts of anhydrous ethanol free chloroform is ffaddeddropwisetoa solution of 142.9 parts of 13-methylf 17 fvinyl F 17-hydroxy51,2,3,6,7,8,9,10,11,12,13,14,16,17- itetradecahydro-15H cyclopenta [a1phenanthren-3-one in 2250fparts of jchlorofqi-m' and 10 parts of pyridine, (maintained at After standing at room, tem- 'p'eraituielfor 16 hours,'the mixture is treated with chloroff orm and thenjsu ccessjivelyf with dilute hydrochloric acid, "dilute sodium "icjarbon ate solution and finally water. After drying over anhydrous sodium sulfate, the chloroform is stripped ofi', leaving as a residue the l7- bromoethylidene) 13 methyl l,2,3,6,7,8,9,10,11,

- 45 parts of 17-(B-bromoethylidene) l3-methyl-1,2,3-

-tilled in vacuum under nitrogen. The residue is extracted by refluxing with boiling petroleum ether and, after stripping of the solvent in vacuo, the residue is chromatographed over 4500 parts of silica gel. Elution with a 3% solution of ethyl acetate in benzene, evapora- ,tion of the solvent from the eluate and crystallization of the residue from aqueous acetone and petroleum ether J yields 13-rnethyl-17-vinyl-1,2,3,6,7,8,9,10,l1,12,13,14-dodecahydro 15H-cyclopenta[alphenanthren-S-one, melting at about l00l01 C. The specific rotation of an 0.66% chloroform solution is [a] =+111. The ultraviolet absorption spectrum of a methanolic solution shows a.

maximum at 237 millimicrons with a molecular extinction coefiicient of 30,200. This compound has the structural formula Elution of the chromatography column with a 10% solution of ethyl acetate in benzene, evaporation of the solvent from the eluate and crystallization of the residue from aqueous acetone yields the 17 p3-acetoxyethylidene)- 13-methyll,2,3,6,7,8,9,l0,11,l2,13,14,16,17-tetradecahydro 15H cyclopentaEaJphenanthren 3 one. This compou'nd is obtained in two polymorphic crystalline forms, 7 one melting at 49-50 C., the other melting at about 96- 97 C. The specific rotation of a 1% chloroform solution The ultraviolet absorption spectrum of a methanolic solution shows a maximum at 241 milli- 7 microns with a molecular extinction coeflicient of 17,800.

This compound has the structural formula CHgO-O C-CHS Example 2 1000 parts of a 2-N potassium hydroxide solution in '1 75% aqueous methanol are treated with 45.9 partsof 17-(B-acetoxyethy1idene)-13-methyl- 1,2,3,'6,7,8,9,10,11,-

12,13,l4,16,17-tetradecahydro-1SH-cyclopentaiaJphenanthr'en-3-one and refluxed for 17 minutes. Water is added to turbidity and the mixture is cooled to 0C. The precipitate is collected on a' filter, washed with water and dissolved in ethyl acetate.

with charcoal, concentrated to one-third of its volume and treated with petroleum ether to induce crystallization. The 17-(B-hyd'roxyethylidene) -13-methy11,2,3,

4 8,9,10,11,12,13,14,16,17-tetradecahydro-15H cyclcpenta- [alphenanthren-B-one thus obtained melts at about l51l53 C. The identical product is obtained by alkaline hydrolysis in methanol of the l7-(;8-bromoethylidene)-13-methyl 1,2,3,6,7,8,9,10,11,l2,l3,14,16,l7- tetradecahydro-15H-cyclopenta[a] phenanthren-3-one obtained in Example 1. A mixed melting point test of the material obtained by these two methods shows no depression. A 1% chloroform solution shows an optical rotation [a] =+51. The product has the structural formula CHZOH Example 3 1 part of 13-methyl-17-hydroxy-17-(B-acetoxy-ethylidene)-1,2,3,6,7,8,9,l0,11,l2,l3,l4,16,17 tetradecahydro- 15H-cyclopentala]phenanthren-3-one is stirred with 5000 parts of citrated beef blood and 5000 parts of 0.85% aqueous sodium chloride solution. This solution is perfused three times through a surviving beef adrenal, which is cannulated through the vein and has a finely lacerated surface. The perfusate is then extracted with isopropyl acetate. The extract is dried by azeotropic distillation and then concentrated to a residue of about 20 parts. After dilution with 380 parts of henzene the solution is poured into a chromatography column consisting of 90 parts of silica gel. Elution with 1200 parts of a 10% solution of ethyl acetate in benzene and 600 parts of a 20% solution of ethyl acetate in benzene yields mainly cholesterol. The column is then eluted with 600 parts of a 33% solution of ethyl acetate in benzene; concentration yields the 13-methyl-17-(B- hydroxylethylidene) 1,2,3,6,7,8,9,10,11,l2,l3,l4,16,l7- tetradecahydro-lSH-cyclopenta[a]phenanthren 3 one, which recrystallized from petroleum ether, melts at about The column is washed with 1200 parts of a 50% and with 300 parts of a 66% solution of ethyl acetate in benzene. Subsequent elution with 300 parts of a 33% solution and 600 parts of a 20% solution of benzene in ethyl acetate yields 1lfi-hydroxy-l3-methyl-l7-(B-hydroxyethylidene)-1,2,3,6,7,8,9,10,11,12,13,14,16,17-tetradecahydro 15I-I-cyclopenta[alphenanthren-3-one which, crystallized twice from ethyl acetate, melts at about 168- 170 C. This compound gives a negative blue tetrazolium test and a 1% chloroform solution shows a molecular The solution is decolorized rotation of [al ='+89. The ultraviolet absorption spectrum has a maximum at 242 millimicrons with a molecular extinction coefiicient of 17,300. This compound has the structural formula CH:OH

H CH: OH] (I HO-C on, he $11 in.

Example 4 A mixture of parts of 11B-hydroxy-13-methyl-17- (B-hydroxyethylidene) -l,2,3,6,7,8,9,10,11,l2,13,14,16,17- tetradecahydro-lSH-cyclopentala]phenanthren-S-one, 139

parts of sodium acetate,.'700 partsof acetic anhydride and 1000 parts of glacial acetic acid is kept at roomtemperature for 4 hours and then treated by the gradual addition of chipped ice to induce crystallization. After standing for 1 hour the reaction mixture is filtered and i Example 5 Toa mixture of 119 parts of 1 l fi hydroxy-lfi-methyl- 17 (B-acetoxyethylidene)-1,2,3,6,7,8,9,10,11,12,13,14,l6, 17 tetradecahydro-lSH-cyclopenta[a]phenanthren-3-one in 2000 parts of butanol and 46 parts of hydrogen peroxide in 3000 parts of butanol, 11 parts of osmium tetroxide in 1000 parts of butanol are added in the course of 12 minutes. An additional quantity of 11 parts of osmium tetroxide in 1000 parts of butanol is added in the course of the following 2 hours at room temperature to the reaction mixture which turns greenish-brown upon standing at room temperature for 24 hours. Then 20,000 parts of water are added and the mixture is concentrated under vacuum to one-fifth of its original volume. The residue is extracted with ethyl acetate and is dried over anhydrous sodium sulfate and concentrated under vacuum. The resulting residue is taken up in aqueous methanol and treated with 50 parts of aqueous sodium sulfite. After refluxing for 30 minutes the reaction mixture is concentrated, diluted with water and extracted with ethyl acetate. The extract is dried over sodium sulfate, filtered and evaporated to dryness. The residue is dissolved in a solution of ethyl acetate in benzene and applied to a silica gel chromatography column. The

column is rinsed with benzene and 10% ethyl acetate in benzene. Elution with a 50% solution of ethyl acetate in benzene yields 11,,17-dihydroxy-17-(fi-hydroxyacetyl)- 1,2,3,6,7,8,9,10,l1,12,13,14,16,17 tetradecahydro H- cyclopenta[aJphenanthren-3-one which has the structural formula The compound gives a positive blue tetrazolium test. The ultraviolet absorption spectrum shows a maximum at 242 millimicrons with a molecular extinction coefi'icient of about 17,300.

Example 6 To a solution of 22 parts of 11p,17-dihydroxy-l7-(B- hydroxyacetyl) 1,2,3,6,7,8,9,10,11,12,13,14,16,17 tetradecahydro-15H-cyclopenta[alphenanthren-3-one in 500 parts of pyridine are added 325 parts of acetic anhydride. The mixture is permitted to stand at room temperature for 90 minutes. Then ice is added and, after 45 minutes, the reaction mixture is treated with 0.5-N hydrochloric acid. The mixture is extracted with ethyl acetate and the extract is washed with water, saturated with sodium bicarbonate and again with water, dried and evaporated under vacuum. The residue is applied to a silica gel chromatography column. Elution with a 40% solution of ethyl acetate in benzene yields an acetyl derivative which on recrystallization from acetone and water, melts at about 208-211" C. The infrared absorption spectrum 10.78, 11106, =1i1.22, 1 1.-53, microns.

shows .maxima at 2.88, 5.71, 5.78, 6.03, 6.21, 6.90, 7.08, 7.30, 7.52, 7.88,r8.10,=8.32,8.82, 9.03, 9.50, 10.06, 10.22,

To 234 parts of this acetyl derivative are added 44 .parts IOfiChl'OIIl-lC acid in 0:1-N glacial acetic acid solution.

The mixture is stirred for i30'minutes at room temperature, diluted with waterandextracted with chloroform.

The chloroform extract iswashed successively with.5% aqueous sodium bicarbonate solution and water andtevaporated to dryness. i17he ,13-imethy1-17-hydroxy-17- (ti-acetoxyacetyl)1,2,3,6,7,8,9,l0,11,12,13,14,16,17 tetradecahydro-15H-cyclopenta[a]phenanthrene-3,1l-dione is recrystallized from ethyl acetate and obtained in beautiful colorless crystals. The ultraviolet absorption spectrum of a methanolic solution shows a maximum at about 239 millimicrons with an extinction coefiicient of about 16,750. The infrared absorption spectrum shows maxima of 2.75, 2.85, 5.83, 6.02, 6.20 and an inflection point at 5.76 microns. The compound gives a positive blue tetrazolium test.

Example 7 A mixture of 29 parts of 13-methyl-17-hydroxy-17- (/8 acetoxyacetyl) 1,2,3,6,7,8,9,10,11,.l2,14,l6,17-tetradecahydro-ISH-cyclopenta [a]phenanthrene-3,11 dione in 1500 parts of aqueous methanol and 1800 parts of hot aqueous l-N hydrochloric acid is refluxed under a nitrogen atmosphere for 5 hours, chilled and concentrated in vacuum to one-fourth of its original volume. After cooling to 0 C., the product is collected on a filter. Colorless crystals are obtained on recrystallization from ethyl acetate. The product gives a positive blue tetrazolium test. The ultraviolet absorption spectrum of a methanolic solution gives a maximum at about 239 millimicrons with an extinction coefiicient of about 16,900. The infrared absorption spectrum shows maxima at 2.77, 2.83, 5.83, 6.02 and 6.20 microns. The 13- methyl-17-hydroxy-l7 (B-hydroxyacetyl) 1,2,3,6,7,8,9, 10,l1,12,13,14,16,17 tetradecahydro 15H-cyclopenta [a]phenanthrene-3,1l-dione has the structural formula I claim: 1. A compound of the structural formula (IJHZOR C=O T wherein X is a member of the class consisting of carbinol and carbonyl radicals, and R is a member of the class consisting of hydrogen and (lower alkyl)-CO-- radicals.

1 1.77, 12.72 and 12.90

2. 13-Methy1-11p,17 dihydroxy-17 (fi-hydroxyace- 6. An acetate of the compound of the structural tyl) 1,2,3,6,7,8,9,10,11,12,13,14,16,17 tetradecahydroformula- 'ISH-cyclopentalEaJphenanthrene-B-one. $112011 3. 13-Methy1- 17-hydroxy-17 (fi-hydroxyacetyl)-1,2, CHI :0 3,6,7,8,9,10,11,12,13,14,16,17 tetradecahydro 15H- 5 '7 HO cyclopenta [a] phenanthrene-3,1 l-dione.

4. 13-Methyl 113,17-dihydroxy-17 (fl-acetoxyace- H tyl) 1,2,3,6,7,8,9,10,11,12,13,14,16,17 tetradecahydro- ISH-cycolepenta[a]phenanthrene-3-one.

5. 13-Methyl-17-hydroxy-17 (p-acetoxyacetyl) 1,2, 10 0= 3,6,7,8,9,10,11,12,13,14,16,17 tetradecahydro 15H- cyclopenta[a]phenanthrene-3,1l-dione, References Cited 1n the file of thxs patent UNITED STATES PATENTS 2,183,589 Reichstein Dec. 19, 1939 

1. A COMPOUND OF THE STRUCTURAL FORMULA 